Abstract
On August 8, 2012, after the manuscript: Can Male Vaccination Reduce the Burden of Human Papillomavirus-Related Disease in the United States? by Garren M.I. Low, Yasser S. Attiga, Gaurav Garg, Richard Schlegal, and G. Ian Gallicano was published online, the authors contacted the editorial office to state that a coauthor had a previously undisclosed conflict of interest: Georgetown University and R. S. receive royalty payments for the development and commercialization of the HPV vaccine technology. We have corrected their article both online and in print, but wish to bring this information to your attention. Full disclosure of conflicts of interest is paramount to our journal and we strive to make sure we present our readers with all information that may influence the interpretation of results we publish.
David L. Woodland
Editor-in-Chief
We sincerely regret the failure to disclose our related financial interest at the time of submission. We recognize the gravity of this oversight, and immediately attempted to disclose it as soon as we discovered the omission. We apologize for any inconvenience or confusion this may have created for the publisher, the editors, and our scientific colleagues. We have asked all co-authors to disclose this information should they be contacted by others about the paper, including members of the press.